Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sarcoglycanopathies: an update.

Neuromuscular disorders : NMD - 1 Oct 2021

Vainzof Mariz, Souza Lucas S, Gurgel-Giannetti Juliana, Zatz Mayana

Abstract excerpt

Sarcoglycanopathies are the most severe forms of autosomal recessive limb-girdle muscular dystrophies (LGMDs), constituting about 10-25% of LGMDs. The clinical phenotype is variable, but onset is usually in the first decade of life. Patients present muscle hypertrophy, elevated CK, variable muscle weaknesses, and progressive loss of ambulation. Four subtypes are known: LGMDR3, LGMDR4, LGMDR5 and LGMDR6, caused,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dependovirus
Share to Genetic Neurodegenerative Diseases
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Muscle Physiology and Disorders

Share to Muscle, Skeletal

Share to Mutation

Share to Phenotype

Share to Sarcoglycans

Source

Identifiers

PMID: 34404573
DOI: 10.1016/j.nmd.2021.07.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sarcoglycanopathies: an update.PMID 34404573Read ↗

Genetic spectrum of sarcoglycanopathies in a cohort of Russian patients.Semantic proximity Read ↗

Clinical and genetic spectrum of a large cohort of patients with δ-sarcoglycan muscular dystrophySemantic proximity Read ↗

[Sarcoglycanopathies: state of the art and therapeutic perspectives].Semantic proximity Read ↗

Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of Chinese patientsSemantic proximity Read ↗

Sarcoglycanopathies: a clinico-pathological study.Semantic proximity Read ↗

Sarcoglycanopathies: molecular pathogenesis and therapeutic prospectsSemantic proximity Read ↗

Revised spectrum of mutations in sarcoglycanopathies.Semantic proximity Read ↗

From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy.Semantic proximity Read ↗

Sarcoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian populationSemantic proximity Read ↗

LGMD2E is the most common type of sarcoglycanopathies in the Iranian population.Semantic proximity Read ↗

Profiling of pathogenic variants in Japanese patients with sarcoglycanopathy.Semantic proximity Read ↗

Very late-onset limb-girdle muscular dystrophy type 2D: A milder form with a normal muscle biopsy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.